SMPD1 and early-onset autosomal dominant Alzheimer disease: It has been reported that aSMase-deficient mice show a broad range of abnormalities in the central nervous system193, and aSMase can modulate autophagic processes in Alzheimer’s disease by modulating lysosomal biogenesis194.